Advertisement

Intraoral mass, extraoral suppuration, and jaw lesions

Published:September 26, 2021DOI:https://doi.org/10.1016/j.oooo.2021.09.010
      A 77-year-old African American man with a 1-year history of an asymptomatic intraoral mass and facial edema was referred by his physician for specialized oral medicine evaluation at our department. His medical condition pointed to systemic arterial hypertension controlled with medications. His blood test results indicated elevated creatinine and urea (1.64 mg/dL and 80 mg/dL, respectively). Additionally, the patient's medical history did not indicate any antiresorptive or other drug that could alter bone remodeling, as well as radiotherapy in the head and neck region.
      To read this article in full you will need to make a payment

      References

        • Goetze E
        • Walter C
        • Kämmerer PW.
        Osseous plasma cell neoplasm of the mandible for initial diagnosis of multiple myeloma: case report and literature review.
        J Maxillofac Oral Surg. 2015; 14: 469-474
        • Zaidi AA
        • Vesole DH.
        Multiple myeloma: an old disease with new hope for the future.
        CA Cancer J Clin. 2001; 51 (quiz 286-289): 273-285
        • Palumbo A
        • Anderson K.
        Multiple myeloma.
        N Engl J Med. 2011; 364: 1046-1060
        • Troeltzsch M
        • Oduncu F
        • Mayr D
        • Ehrenfeld M
        • Pautke C
        • Otto S.
        Root resorption caused by jaw infiltration of multiple myeloma: report of a case and literature review.
        J Endod. 2014; 40: 1260-1264
        • Faria KM
        • Ribeiro ACP
        • Brandão TB
        • et al.
        Radiographic patterns of multiple myeloma in the jawbones of patients treated with intravenous bisphosphonates.
        J Am Dent Assoc. 2018; 149: 382-391
        • Lee SH
        • Huang JJ
        • Pan WL
        • Chan CP.
        Gingival mass as the primary manifestation of multiple myeloma: report of two cases.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996; 82: 75-79
        • Faustino ISP
        • Fernandes PM
        • Pontes HAR
        • et al.
        Langerhans cell histiocytosis in the oral and maxillofacial region: an update.
        J Oral Pathol Med. 2021; 50: 565-571
        • Neves-Silva R
        • Fernandes DT
        • Fonseca FP
        • et al.
        Oral manifestations of Langerhans cell histiocytosis: a case series.
        Spec Care Dentist. 2018; 38: 426-433
        • Luz J
        • Zweifel D
        • Hüllner M
        • et al.
        Oral manifestation of Langerhans cell histiocytosis: a case report.
        BMC Oral Health. 2018; 18: 106
        • DiCaprio MR
        • Roberts TT.
        Diagnosis and management of Langerhans cell histiocytosis.
        J Am Acad Orthop Surg. 2014; 22: 643-652
        • Vered M
        • Muller S
        • Heikinheimo K.
        Odontogenic and maxillofacial bone tumors – ameloblastoma.
        WHO Classification of Head and Neck Tumours. 4th ed. IARC Press, Lyon, France2017: 215-217
        • Hendra FN
        • Kalla DSN
        • Cann EMV
        • de Vet HCW
        • Helder MN
        • Forouzanfar T.
        Radical vs conservative treatment of intraosseous ameloblastoma: systematic review and meta-analysis.
        Oral Dis. 2019; 25: 1683-1696
        • Odell EW
        • Muller S
        • Richardson M.
        Odontogenic and maxillofacial bone tumors – ameloblastic carcinoma.
        WHO Classification of Head and Neck Tumours. 4th ed. IARC Press, Lyon, France2017: 206-207
        • Deng L
        • Wang R
        • Yang M
        • Li W
        • Zou L.
        Ameloblastic carcinoma: clinicopathological analysis of 18 cases and a systematic review.
        Head Neck. 2019; 41: 4191-4198
        • Fraser W.D.
        Hyperparathyroidism.
        Lancet. 2009; 374: 145-158
        • Bilezikian JP
        • Bandeira L
        • Khan A
        • Cusano N.E.
        Hyperparathyroidism.
        Lancet. 2018; 391: 168-178
        • Palla B
        • Burian E
        • Fliefel R
        • Otto S.
        Systematic review of oral manifestations related to hyperparathyroidism.
        Clin Oral Investig. 2018; 22: 1-27
        • Scully C
        • Langdon J
        • Evans J.
        Marathon of eponyms: 7 Gorlin-Goltz syndrome (naevoid basal-cell carcinoma syndrome).
        Oral Dis. 2010; 16: 117-118
        • Bresler SC
        • Padwa BL
        • Granter SR.
        Nevoid basal cell carcinoma syndrome (Gorlin syndrome).
        Head Neck Pathol. 2016; 10: 119-124
        • Alves DBM
        • Tuji FM
        • Alves FA
        • et al.
        Evaluation of mandibular odontogenic keratocyst and ameloblastoma by panoramic radiograph and computed tomography.
        Dentomaxillofac Radiol. 2018; 4720170288
        • Al-Moraissi EA
        • Dahan AA
        • Alwadeai MS
        • et al.
        What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor? A large systematic review and meta-analysis.
        J Craniomaxillofac Surg. 2017; 45: 131-144
        • Roberts AE
        • Allanson JE
        • Tartaglia M
        • Gelb BD
        Noonan syndrome.
        Lancet. 2013; 381: 333-342
        • Lutz JC
        • Nicot R
        • Schlund M
        • et al.
        Dental and maxillofacial features of Noonan syndrome: case series of ten patients.
        J Craniomaxillofac Surg. 2020; 48: 242-250
        • Poladian K
        • Difato TC
        • Anderson KL
        • Taylor SL.
        Gorlin syndrome in a patient with skin type VI.
        Dermatol Online J. 2019; 25: 8
        • Bree AF
        • Shah MR
        • BCNS Colloquium Group
        Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS).
        Am J Med Genet Part A. 2011; 155: 2091-2097